Static Chart PHAXIAM Therapeutics S.A. Euronext Paris

Equities

Market Closed - Euronext Paris Other stock markets 11:35:17 2024-05-20 am EDT			5-day change	1st Jan Change
3.055 ^EUR	0.00%		+2.86%	-33.59%

Apr. 15	Phaxiam initiates trial in infective endocarditis	CF
Apr. 15	PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus	CI

Duration

Period